ABSTRACT
Introduction
Periodically updated guidelines have been integral to the field of cardiac arrest resuscitation since the first consensus publication of standardized treatment recommendations in 1966.
(1) The first American Heart Association (AHA) "standards for resuscitation" were published in 1974, (2) an subsequently updated as "guidelines" in 1980, 1986, and 1992 . The process became formally international when the International Liaison Committee on Resuscitation (ILCOR) published its first set of "advisory statements" in 1997. (3, 4) In collaboration with the AHA, ILCOR produced the first International cardiopulmonary resuscitation (CPR) Guidelines in 2000 and an International Consensus on CPR (cardiopulmonray resuscitation) and ECC (emergency cardiac care) Science with Treatment Recommendations (CoSTR) in 2005. In the fall of 2010, the latest ILCOR CoSTR will be published. This consensus document will be used by ILCOR member councils to develop and disseminate their 2010 treatment guidelines. Along with advances in the science of resuscitation, the process for developing clinical practice guidelines has changed dramatically over that past 44 years. In fact, the guidelines development process itself has become the subject of expanding scientific investigation. For resuscitation guidelines to have the greatest impact on patient outcomes, the science of guideline development should be embraced along with the science of resuscitation. With the latest 5-year cycle of evidence evaluation and guideline development completed, we have an valuable opportunity to reflect on the process and identify ways to advance the science of guideline development in the field of cardiopulmonary resuscitation and emergency cardiac care.
Looking Back: Evaluating the 2010 Guidelines Process
As mentioned above, the clinical practice guideline development process has become the subject of increasing scientific investigation. The Appraisal of Guidelines for Research and Evaluation (AGREE) instrument was developed and published by the AGREE (5) AGREE is an internationally validated appraisal instrument for assessing the quality of clinical practice guidelines. AGREE II consists of 23 key items organized within 6 domains followed by 2 global rating items ("Overall Assessment"). Each domain captures a unique dimension of guideline quality (table 1) . (6) Using AGREE II to assess the 2010 ILCOR CoSTR and 2010 ILCOR member council guidelines will be an important initial step in planning for the next round of evidence evaluation and guideline development. Overall, the process and product is likely to score high marks. Particular strengths based on AGREE II criteria are likely to be a well-defined scope and purpose, the rigor of development, and editorial independence as it relates to conflict of interest management. Potential areas for improvement include stakeholder involvement, clarity of presentation, and applicability. Although relevant professional disciplines are well-represented on ILCOR task forces and the guidelines writing groups of member councils, the opportunity for input from lay providers, patients, and patient families is limited. The value of this input is becoming increasingly recognized. (7) In the clarity of presentation domain, it remains challenging to make specific and unambiguous recommendations in areas where the science is inadequate. A transparent process that clearly defines the quality and quantity of evidence supporting individual treatment recommendations is essential. 
Domain
Items in Domain
Scope and purpose
The overall objective(s) of the guideline is (are) specifically described
The clinical question(s) covered by the guideline is (are) specifically described
The patients to whom the guideline is meant to apply are specifically described
Stakeholder involvement
The guideline development group includes individuals from all relevant professional groups
The patients' views and preferences have been sought
The target users of the guideline are clearly defined
The guideline has been piloted among end users
Rigor of development
Systematic methods were used to search for evidence
The criteria for selecting the evidence are clearly described
The methods for formulating the recommendations are clearly described
The health-related benefits, side effects and risks have been considered in formulating the recommendations
There is an explicit link between the recommendations and the supporting evidence
The guideline has been externally reviewed by experts prior to its publication A procedure for updating the guideline is provided
Clarity of presentation
The recommendations are specific and unambiguous
The different options for management of the condition are clearly presented
Key recommendations are easily identifiable
The guideline is supported with tools for application
Applicability
The potential organizational barriers in applying the recommendations have been discussed The potential cost-related implications of applying the recommendations have been considered The guideline presents key review criteria for monitoring and/or audit purposes
Editorial independence
The guideline is editorially independent from the funding body
Conflicts of interest of members of the guideline development group have been recorded
Looking Forward: The Future of CPR and ECC Guidelines
Moving forward, a critical appraisal of the one-size-fits all approach to instruction and treatment is indicated. If the ultimate goal is for every patient to have CPR initiated immediately once cardiac arrest is recognized, novel strategies are needed to empower the cardiac arrest witness to take effective action. Traditional CPR training courses continue to reach a limited audience, and both the effectiveness and efficiency of this process has come into question. Dispatcher assisted CPR, hands-only CPR, (11) and smart phone applications provide examples of innovative strategies. Optimizing these and other novel approaches to empower every potential cardiac arrest witness to act could have dramatic impact on out-ofhospital cardiac arrest outcomes. For the professional provider, the onesize-fits all approach will eventually be recognized as a fundamental barrier to improving outcomes. Standardized treatment guidelines and algorithms attempt to define care that is optimal for the majority of patients with a given presentation. However, the tremendous variability in patients suffering cardiac arrest suggests that this approach might be optimal for only a minority of patients. To overcome this barrier, individualized treatment strategies titrated to real-time physiologic monitoring will be needed. This approach could be further enhanced by mechanized delivery of therapies that automatically adjust in real time to optimize physiologic parameters.
Finally real-time computer-aided medical decision support based on multiple physiologic parameters might also be used to guide management. (12) Optimization of available physiologic monitoring techniques such as quantitative waveform capnography, VF (ventricular fibrillation) waveform analysis, and ECG filtering to removed CPR artifact will provide important initial steps. However, novel techniques for real-time continuous monitoring of organ-specific metabolism during CPR, especially for the heart and brain, might be the breakthrough needed to drive a true paradigm shift. Once this is achieved, an individualized goaldirected approach to cardiac arrest resuscitation could revolutionize the way treatment guidelines are developed, implemented and evaluated.
